Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways

References

• Janvilisri T Omics-based identification of biomarkers for nasopharyngeal carcinoma. Disease markers. 2015;2015:762128. doi:10.1155/2015/762128. PMID:25999660
   PubMed Web of Science ®Google Scholar
• Wu Z, Weng D, Li G. Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3 gamma as a novel biomarker in nasopharyngeal carcinoma. Journal of proteomics. 2013;83:26-36. doi:10.1016/j.jprot.2013.03.001. PMID:23500129
   PubMed Web of Science ®Google Scholar
• Arnold M, Wildeman MA, Visser O, Karim-Kos HE, Middeldorp JM, Fles R, Bing Tan I, Coebergh JW. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology. Oral oncology. 2013;49:237-43.
   PubMed Web of Science ®Google Scholar
• Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chinese journal of cancer. 2014;33:381-7. PMID:25096544
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Antoni S, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. International journal of cancer. 2015;137:2060-71. doi:10.1002/ijc.29670. PMID:26135522
   PubMed Web of Science ®Google Scholar
• Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K. Nasopharyngeal carcinoma: the next challenges. European journal of cancer. 2010;46:1967-78. doi:10.1016/j.ejca.2010.04.004. PMID:20451372
   PubMed Web of Science ®Google Scholar
• Ben Chaaben A, Busson M, Douik H, Boukouaci W, Mamoghli T, Chaouch L, Harzallah L, Dorra S, Fortier C, Ghanem A, et al. Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension. Tissue antigens. 2011;78:148-51. doi:10.1111/j.1399-0039.2011.01702.x. PMID:21623733
   PubMedGoogle Scholar
• Li M, Dai W, Zhou H. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis. TheScientificWorldJournal. 2013;2013:689048. doi:10.1155/2013/689048. PMID:24222746
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000–2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Seminars in cancer biology. 2012;22:107-16. doi:10.1016/j.semcancer.2012.01.007. PMID:22300735
   PubMed Web of Science ®Google Scholar
• Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Seminars in radiation oncology. 2012;22:233-44. doi:10.1016/j.semradonc.2012.03.008. PMID:22687948
   PubMed Web of Science ®Google Scholar
• Anderson P, Dische S. Local tumor control and the subsequent incidence of distant metastatic disease. International journal of radiation oncology, biology, physics 1981;7:1645-8. doi:10.1016/0360-3016(81)90186-3. PMID:7037703
   PubMed Web of Science ®Google Scholar
• Mlecnik B, Bindea G, Kirilovsky A, Angell HK, Obenauf AC, Tosolini M, Church SE, Maby P, Vasaturo A, Angelova M, et al. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci Transl Med. 2016;8:327ra26. doi:10.1126/scitranslmed.aad6352. PMID:26912905
   PubMed Web of Science ®Google Scholar
• Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clinical & Experimental Metastasis. 2009;26:19-34. doi:10.1007/s10585-008-9182-2
   PubMed Web of Science ®Google Scholar
• Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nature Reviews Cancer. 2005;5:516. doi:10.1038/nrc1650. PMID:15965493
   PubMed Web of Science ®Google Scholar
• Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E, Yue S, O'Sullivan B, Liu FF. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell death & disease. 2010;1:e85. doi:10.1038/cddis.2010.64
   PubMed Web of Science ®Google Scholar
• Lin YH, Chang KP, Lin YS, Chang TS. Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Radiation oncology. 2015;10:136. doi:10.1186/s13014-015-0443-3. PMID:26122711
   PubMed Web of Science ®Google Scholar
• Lee SW, Chen TJ, Lin LC, Li CF, Chen LT, Hsing CH, Hsu HP, Tsai CJ, Huang HY, Shiue YL. Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma. Experimental and molecular pathology. 2013;95:83-90. doi:10.1016/j.yexmp.2013.05.006. PMID:23726796
   PubMed Web of Science ®Google Scholar
• Abdulkarim B, Deutsch E. Endothelial-cell apoptosis and tumour response to radiotherapy. Lancet Oncology. 2004;5:9. doi:10.1016/S1470-2045(03)01317-2. PMID:14700602
   PubMed Web of Science ®Google Scholar
• Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, Gulavita S, Patel S, Sun X, Chen J, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 2009;20:375101. doi:10.1088/0957-4484/20/37/375101. PMID:19706948
   PubMed Web of Science ®Google Scholar
• Shiloh Y. ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochemical Society transactions. 2001;29:661-6. doi:10.1042/bst0290661. PMID:11709050
   PubMed Web of Science ®Google Scholar
• Sommer SS, Jiang Z, Feng J, Buzin CH, Zheng J, Longmate J, Jung M, Moulds J, Dritschilo A. ATM missense mutations are frequent in patients with breast cancer. Cancer genetics and cytogenetics. 2003;145:115-20. doi:10.1016/S0165-4608(03)00119-5. PMID:12935922
   PubMedGoogle Scholar
• Abraham RT Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes & development. 2001;15:2177-96. doi:10.1101/gad.914401
   PubMed Web of Science ®Google Scholar
• Chen Y, Poon RY. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. Frontiers in bioscience: a journal and virtual library. 2008;13:5016-29. PMID:18508566
   PubMed Web of Science ®Google Scholar
• Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes & development. 2000;14:1448-59.
   PubMed Web of Science ®Google Scholar
• Feng XH, Liang YY, Liang M, Zhai W, Lin X. Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-beta-Mediated Induction of the CDK Inhibitor p15(Ink4B). Molecular cell. 2016;63:1089. doi:10.1016/j.molcel.2016.08.027. PMID:27618489
   PubMed Web of Science ®Google Scholar
• Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. The Journal of biological chemistry. 2000;275:29244-56. doi:10.1074/jbc.M909467199. PMID:10878024
   PubMed Web of Science ®Google Scholar
• Millet C, Zhang YE. Roles of Smad3 in TGF-beta signaling during carcinogenesis. Critical reviews in eukaryotic gene expression. 2007;17:281-93. doi:10.1615/CritRevEukarGeneExpr.v17.i4.30. PMID:17725494
   PubMed Web of Science ®Google Scholar
• Zhang S, Ekman M, Thakur N, Bu S, Davoodpour P, Grimsby S, Tagami S, Heldin CH, Landström M. TGFβ1-Induced Activation of ATM and p53 Mediates Apoptosis in a Smad7-Dependent Manner. Cell Cycle. 2006;5:2787-95. doi:10.4161/cc.5.23.3523. PMID:17172861
   PubMed Web of Science ®Google Scholar
• Dunne AL, Price ME, Mothersill C, Mckeown SR, Robson T, Hirst DG. Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells. British Journal of Cancer. 2003;89:2277. doi:10.1038/sj.bjc.6601427. PMID:14676806
   PubMed Web of Science ®Google Scholar
• Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. (−)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Mol Cancer Ther. 2005;4:197-205. PMID:15713891
   PubMed Web of Science ®Google Scholar
• Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ, Reis C, Dahm K, Fricke A, Krempler A, et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Molecular cell. 2004;16:715-24. doi:10.1016/j.molcel.2004.10.029. PMID:15574327
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo O, Celeste A, Nussenzweig A. Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell cycle. 2003;2:426-7. doi:10.4161/cc.2.5.509. PMID:12963833
   PubMed Web of Science ®Google Scholar
• Anderson JA, Harper JV, Cucinotta FA, O'Neill P. Participation of DNA-PKcs in DSB repair after exposure to high- and low-LET radiation. Radiation research. 2010;174:195-205. doi:10.1667/RR2071.1. PMID:20681786
   PubMed Web of Science ®Google Scholar
• Cucinotta FA, Pluth JM, Anderson JA, Harper JV, O'Neill P. Biochemical kinetics model of DSB repair and induction of gamma-H2AX foci by non-homologous end joining. Radiation research. 2008;169:214-22. doi:10.1667/RR1035.1. PMID:18220463
   PubMed Web of Science ®Google Scholar
• Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic acids research. 2008;36:5678-94. doi:10.1093/nar/gkn550. PMID:18772227
   PubMed Web of Science ®Google Scholar
• Redon CE, Dickey JS, Bonner WM, Sedelnikova OA. γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. Advances in Space Research the Official Journal of the Committee on Space Research. 2009;43:1171-8. doi:10.1016/j.asr.2008.10.011
   PubMed Web of Science ®Google Scholar
• Sato K, Nishikino M, Okano Y, Ohshima S, Hasegawa N, Ishino M, et al. gamma-H2AX and phosphorylated ATM focus formation in cancer cells after laser plasma X irradiation. Radiation research. 2010;174:436-45. doi:10.1667/RR2178.1. PMID:20718602
   PubMed Web of Science ®Google Scholar
• Ji J, Zhang Y, Redon CE, Reinhold WC, Chen AP, Fogli LK, Holbeck SL, Parchment RE, Hollingshead M, Tomaszewski JE, et al. Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay. PLoS One. 2017;12:e0171582. doi:10.1371/journal.pone.0171582. PMID:28158293
   PubMed Web of Science ®Google Scholar
• Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF, et al. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Molecular and cellular biology. 2005;25:3338-47. doi:10.1128/MCB.25.8.3338-3347.2005. PMID:15798217
   PubMed Web of Science ®Google Scholar
• Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunology letters. 2002;82:85-91. doi:10.1016/S0165-2478(02)00023-8. PMID:12008039
   PubMed Web of Science ®Google Scholar
• Ten Dijke P, Goumans MJ, Itoh F, Itoh S. Regulation of cell proliferation by Smad proteins. Journal of cellular physiology. 2002;191:1-16. doi:10.1002/jcp.10066. PMID:11920677
   PubMed Web of Science ®Google Scholar
• Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. The EMBO journal. 2000;19:1745-54. doi:10.1093/emboj/19.8.1745. PMID:10775259
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577-84. doi:10.1038/nature02006. PMID:14534577
   PubMed Web of Science ®Google Scholar
• Wiegman EM, Blaese MA, Loeffler H, Coppes RP, Rodemann HP. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2007;83:289-95. doi:10.1016/j.radonc.2007.05.013. PMID:17560675
   PubMed Web of Science ®Google Scholar
• Lee J, Kim MR, Kim HJ, An YS, Yi JY. TGF-beta1 accelerates the DNA damage response in epithelial cells via Smad signaling. Biochemical and biophysical research communications. 2016;476:420-5. doi:10.1016/j.bbrc.2016.05.136. PMID:27237972
   PubMed Web of Science ®Google Scholar
• Kirshner J, Jobling MF, Pajares MJ, Ravani SA, Glick AB, Lavin MJ, Koslov S, Shiloh Y, Barcellos-Hoff MH. Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer research. 2006;66:10861-9. doi:10.1158/0008-5472.CAN-06-2565. PMID:17090522
   PubMed Web of Science ®Google Scholar
• Lobrich M, Jeggo PA. The two edges of the ATM sword: co-operation between repair and checkpoint functions. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2005;76:112-8. doi:10.1016/j.radonc.2005.06.027. PMID:16026874
   PubMed Web of Science ®Google Scholar
• Zgheib O, Huyen Y, DiTullio RA, Jr., Snyder A, Venere M, Stavridi ES, et al. ATM signaling and 53BP1. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2005;76:119-22. doi:10.1016/j.radonc.2005.06.026. PMID:16024119
   PubMed Web of Science ®Google Scholar